Technical Analysis for HOOK - HOOKIPA Pharma Inc.

Grade Last Price % Change Price Change
grade F 9.15 -1.19% -0.11
HOOK closed down 1.19 percent on Friday, May 24, 2019, on 21 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
0 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Extremely Strong N/A N/A Down
See historical HOOK trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
New Downtrend Bearish 0.00%
Hot IPO Pullback Bullish Swing Setup 0.00%
NR7 Range Contraction 0.00%
NR7-2 Range Contraction 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Wide Bands Range Expansion 0.00%
Below Lower BB Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%

Older signals for HOOK ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Get Started for Free!
Configure default chart indicators
Basic chart:

Profile
HOOKIPA Pharma Inc., a clinical-stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase 2 clinical trial in cytomegalovirus-negative patients awaiting kidney transplantation from cytomegalovirus-positive donors. Its lead oncology product candidates are HB-201 and HB-202 that are in preclinical studies for the treatment of human papillomavirus-positive cancers. The company has a collaboration with Gilead Sciences, Inc. to develop arenavirus based therapeutics to treat hepatitis B virus and human immunodeficiency virus infections. HOOKIPA Pharma Inc. was founded in 2011 and is headquartered in New York, New York.
Biotechnology Biopharmaceutical Cancer Life Sciences Infectious Diseases Cancers Transplantation Gilead Sciences Immunotherapeutics Viral Disease
Is HOOK a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
May 20 HOOKIPA Pharma misses by $8.00, beats on revenue
May 20 HOOKIPA Pharma Reports First Quarter 2019 Financial Results and Recent Business Highlights
May 13 Alliance Global likes Canopy Growth in premarket analyst action
May 8 HOOKIPA Achieves Research Milestone in HBV Collaboration and License Agreement with Gilead
Apr 25 HOOKIPA Appoints David R. Kaufman to its Board of Directors
Apr 18 Hookipa Pharma shares off to lackluster start in trading debut
Apr 18 5 things to know about Hookipa Pharma ahead of its IPO
Apr 18 HOOKIPA Pharma prices IPO at $14
Apr 18 HOOKIPA Pharma Announces Pricing of Initial Public Offering
Apr 14 IPO Outlook For The Week: Pinterest, Zoom, Biotechs, Minerals And Catastrophe Insurance
See more HOOK news...
Indicators
Indicator Value
52 Week High 14.76
52 Week Low 9.02
Average Volume 74,583
200-Day Moving Average 0.0
50-Day Moving Average 0.0
20-Day Moving Average 12.715
10-Day Moving Average 11.543
Average True Range 0.8124
ADX 77.91
+DI 1.2714
-DI 39.9576
Chandelier Exit (Long, 3 ATRs ) 11.8078
Chandelier Exit (Short, 3 ATRs ) 11.4572
Upper Bollinger Band 16.1459
Lower Bollinger Band 9.2841
Percent B (%b) -0.02
BandWidth 53.966182
MACD Line -1.5276
MACD Signal Line -0.8534
MACD Histogram -0.6742
Fundamentals Value
Market Cap 172.49 Million
Num Shares 18.9 Million
EPS 0.47
Price-to-Earnings (P/E) Ratio 19.59
Price-to-Sales 0.84
Price-to-Book 1.17
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 9.77
Resistance 3 (R3) 9.80 9.63 9.67
Resistance 2 (R2) 9.63 9.47 9.61 9.64
Resistance 1 (R1) 9.39 9.37 9.30 9.36 9.60
Pivot Point 9.21 9.21 9.16 9.19 9.21
Support 1 (S1) 8.97 9.05 8.88 8.94 8.70
Support 2 (S2) 8.79 8.95 8.78 8.66
Support 3 (S3) 8.55 8.79 8.63
Support 4 (S4) 8.53